How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/post-operative-nausea-and-vomiting.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Post-Operative Nausea and Vomiting — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-Operative Nausea and Vomiting (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Post-Operative Nausea and Vomiting, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Anzemet	DOLASETRON	Validus Pharms	Serotonin-3 Receptor Antagonist	5-hydroxytryptamine receptor 3A	1997-01-01
Inapsine	DROPERIDOL	Rising	Dopamine-2 Receptor Antagonist [EPC]	D(2) dopamine receptor	1970-01-01
GRAN®	GRAN®	EVIVE Biotechnology		5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2
Droleptan	Droleptan	Clinique Saint Jean, France		D(4) dopamine receptor, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Clinique Saint Jean, France · 1 drug in Post-Operative Nausea and Vomiting
EVIVE Biotechnology · 1 drug in Post-Operative Nausea and Vomiting
Rising · 1 drug in Post-Operative Nausea and Vomiting
Validus Pharms · 1 drug in Post-Operative Nausea and Vomiting

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Post-Operative Nausea and Vomiting:

Cite this brief

Drug Landscape (2026). Post-Operative Nausea and Vomiting — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/post-operative-nausea-and-vomiting. Accessed 2026-06-10.

Post-Operative Nausea and Vomiting full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing